Scholarlink

Objective <p>This study aimed to investigate the associations between SARS-CoV-2 variants, inflammatory markers, vaccination history, and demographic characteristics in relation to the occurrence of febrile seizures (FS) in pediatric patients at a single tertiary medical center.</p> Methods <p>Retrospective cohort data were collected from a pediatric tertiary care institution between April 2020 and January 2023, encompassing 339 patients with PCR-confirmed SARS-CoV-2 infections. The cohort was separated into FS (<i>n</i> = 102) and control (<i>n</i> = 237) groups. A multivariable logistic regression analysis was employed to evaluate the impact of viral variants (Delta and Omicron sublineages), inflammatory markers (IL-6, D-dimer, CRP), vaccination status (unvaccinated, partially vaccinated, fully vaccinated), and demographic variables, while controlling for potential confounders.</p> Results <p>The incidence of FS among infants under one year of age was found to be 41.2%, in contrast to 17.7% in older children (OR = 3.2, 95% CI: 1.8–5.7; <i>P</i> &lt; 0.001). Elevated levels of IL-6 exceeding 10 pg/mL and D-dimer levels surpassing 0.5&#xa0;mg/L were independently associated with an increased risk of recurrent FS (adjusted OR [aOR] = 2.8 and 2.1, respectively), as well as a 3.1-fold increase in the risk of recurrence. Full vaccination was linked to a 68% reduction in FS risk (aOR = 0.32, 95% CI: 0.18–0.55), particularly benefiting infants. Additionally, male infants exhibited a 1.8-fold increased vulnerability (<i>P</i> = 0.016). Omicron sublineages (BA.5/XBB), which accounted for 78.4% of FS cases, correlated with heightened biomarker levels.</p> Conclusion <p>The findings suggest that IL-6 and D-dimer serve as valuable indicators for assessing the risk of FS in children infected with SARS-CoV-2. The association of vaccination with reduced FS risk suggests potential protective effects, highlighting greater susceptibility among male infants.</p> Key points <p> • Patients with FS had significantly higher IL-6 (&gt; 10 pg/mL) and D-dimer (&gt; 0.5&#xa0;mg/L) levels than controls. These elevations were associated with an increased risk of recurrent FS.</p> <p>• Fully vaccinated children had a 68% lower incidence of FS compared to unvaccinated children.</p> <p>• Male infants showed higher FS incidence (41.2%), consistent with established demographic patterns.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of SARS-CoV-2 variants and vaccination on pediatric febrile seizures: a retrospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月13日

查看全文
  • Mei Yang,
  • Yanzu Wang,
  • Jing Gao,
  • Chunlan Yao,
  • Gangxi Lin,
  • Caijin Yan

摘要

Objective

This study aimed to investigate the associations between SARS-CoV-2 variants, inflammatory markers, vaccination history, and demographic characteristics in relation to the occurrence of febrile seizures (FS) in pediatric patients at a single tertiary medical center.

Methods

Retrospective cohort data were collected from a pediatric tertiary care institution between April 2020 and January 2023, encompassing 339 patients with PCR-confirmed SARS-CoV-2 infections. The cohort was separated into FS (n = 102) and control (n = 237) groups. A multivariable logistic regression analysis was employed to evaluate the impact of viral variants (Delta and Omicron sublineages), inflammatory markers (IL-6, D-dimer, CRP), vaccination status (unvaccinated, partially vaccinated, fully vaccinated), and demographic variables, while controlling for potential confounders.

Results

The incidence of FS among infants under one year of age was found to be 41.2%, in contrast to 17.7% in older children (OR = 3.2, 95% CI: 1.8–5.7; P < 0.001). Elevated levels of IL-6 exceeding 10 pg/mL and D-dimer levels surpassing 0.5 mg/L were independently associated with an increased risk of recurrent FS (adjusted OR [aOR] = 2.8 and 2.1, respectively), as well as a 3.1-fold increase in the risk of recurrence. Full vaccination was linked to a 68% reduction in FS risk (aOR = 0.32, 95% CI: 0.18–0.55), particularly benefiting infants. Additionally, male infants exhibited a 1.8-fold increased vulnerability (P = 0.016). Omicron sublineages (BA.5/XBB), which accounted for 78.4% of FS cases, correlated with heightened biomarker levels.

Conclusion

The findings suggest that IL-6 and D-dimer serve as valuable indicators for assessing the risk of FS in children infected with SARS-CoV-2. The association of vaccination with reduced FS risk suggests potential protective effects, highlighting greater susceptibility among male infants.

Key points

• Patients with FS had significantly higher IL-6 (> 10 pg/mL) and D-dimer (> 0.5 mg/L) levels than controls. These elevations were associated with an increased risk of recurrent FS.

• Fully vaccinated children had a 68% lower incidence of FS compared to unvaccinated children.

• Male infants showed higher FS incidence (41.2%), consistent with established demographic patterns.